 |

Bausch & Lomb ReNu MultiPlus® multi-purpose
solution
Rely on your own professional experience as validation that ReNu MultiPlus multi-purpose solution is a safe and highly effective product. Look at your patients’ eyes, and see for yourself why it has had such a long history of patient and practitioner satisfaction. By understanding what is truly significant, you will be able to provide the best possible care for your patients.

|
|
 |
Silicone hydrogel lens surfaces
Recognizing the Clinical
Realities of Corneal Staining
Evaluating Corneal Staining Data
In our previous edition of Eye Matters, we discussed how a certain
level of low-grade corneal staining is quite common. Because of this, eye care
practitioners must be prepared to differentiate “normal, expected” staining from
“abnormal, needing management” staining.
So how do you
grade the extent and severity of corneal staining and interpret its
significance? The most commonly used grading scheme is some version of this
global 4-step scale
(Image 1):
● Grade 0, of
course, is no staining and ideal.
● Grade 1, trace
staining, is not considered to be clinically significant and so requires no
treatment.
● Grade 2
represents mild staining. Although also not considered to be clinically
significant, it is noteworthy and should be monitored over time.
● Grade 3 is
moderate staining and would imply that therapeutic intervention is appropriate.
● Grade 4 is
severe, requiring treatment.
Image 1 - Global 4-step scale

More detailed evaluation of staining involves an assessment of the type,
depth, and extent of staining. It can be even further detailed by grading those
dimensions individually in each of five corneal zones (Image 2). When the
corneal surface is considered in five zones, staining is described by a “sector
staining score” or by some type of a cumulative staining score made up of 4-step
graded findings from each zone.
Image 2

Once you are familiar with the grading scales, standards
for acceptable levels of staining and definitions of clinical significance, you
will be aware of presentations that sometimes confuse basic principles of
corneal staining.
For instance, when staining data is presented on a
magnified, partial scale, minor differences are over-emphasized (Chart 1). The
same results presented on the FULL 4-step scale now clearly show how the
modified scaling had visually suggested significance where there was none, since
all of the findings are below Grade 1 – less than “trace” amounts (Chart 2).

Another perception “spin” occurs when
an impression of significant difference is created by simply stating that fewer
incidents of staining occurred with lens care product A than with lens care
product B. While that may be a true statement, without statistical support it
has no real practical significance.
Another way to characterize staining
is simply as absent or present, without grading. For instance, one spot of
staining in each of three zones of the cornea could be noted as an incidence in
three out of five zones and reported as 60% staining. However, few clinicians
would agree that three spots are equivalent to 60% staining.
We would encourage all practitioners
to be good interpreters of staining data. Remember that the data can be defined,
organized, analyzed, and presented in ways to spin impressions of significance
that may or may not meet YOUR criteria for clinical significance.
In our next edition of
Eye Matters, we will look at corneal
staining data for ReNu MultiPlus® multi-purpose solution – the number-one
selling multi-purpose solution.
Christopher Snyder, OD
Professor of Optometry & Chief of Contact Lens Patient Care
School of Optometry, University of Alabama at Birmingham
Primary reference:
Snyder C. Solution interaction with ocular surface: The significance in making
the grade. Clin. & Refractive Optometry 2005
©
Bausch & Lomb Incorporated. ®/™ denote trademarks of Bausch & Lomb
Incorporated. Other products/brand names are trademarks of their respective
owners.
|